Latvia, March 23 -- Latvia based SIA "Adaptive" has secured contract from Sabiedriba ar ierobezotu atbildibu "Tiesu namu agentura" for Computer-related equipment Datortehnikas noma. The value of the c... Read More
Lithuania, March 23 -- Lithuania based UAB Armila has secured contract from VsI Vilniaus universiteto ligonine Santaros klinikos (PV) for Pharmaceutical products - purchase of the drug Migalastat hydr... Read More
Netherlands, March 23 -- Netherlands based Beaumont Communicatie & Management B.V. has secured contract from Gemeente Waddinxveen for Advertising and marketing services Communication services. The... Read More
Netherlands, March 23 -- Netherlands based 10BE B.V. has secured contract from Ministerie van Economische Zaken, Rijksdienst voor Ondernemend Nederland (RVO) for Architectural construction engineering... Read More
India, March 23 -- Dr. Reddy's Laboratories announced the launch of its injectable semaglutide under the brand name Obeda', marking an important step in expanding access to advanced GLP?1 receptor ago... Read More
India, March 23 -- The board of Fractal Analytics at its meeting held on 20 March 2026 has approved the investment of USD 0.3 crore, by Fractal Analytics Inc. (Fractal US), wholly owned material subsi... Read More
India, March 23 -- The board of Fractal Analytics at its meeting held 20 March 2026 has approved an increase in the investment limit in Fractal US, a wholly owned material subsidiary of the Company, b... Read More
India, March 23 -- The board of Fractal Analytics at its meeting held 20 March 2026 has approved the investment of Rs 39.4 crore in one or more tranches by way of subscription in equity shares of Anal... Read More
India, March 23 -- The board of Fractal Analytics at its meeting held 20 March 2026 has approved the sale and transfer of the business units namely EdTech, Fractal Analytics Academy (FAA) and Iqigai.a... Read More
India, March 23 -- Zydus Lifesciences has launched Semaglutide Injection under the brand names - SEMAGLYN, MASHEMA and ALTERME, upon patent expiry in India. The Drug Controller General of India (DCGI)... Read More